Responding to Elder Abuse in GERiAtric Care - Dementia

NCT ID: NCT06659822

Last Updated: 2025-04-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

216 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-05-15

Study Completion Date

2025-04-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Abuse of older people is common and people with dementia are especially susceptible to abuse. Older people may be subjected to physical, psychological, sexual, financial abuse or neglect by relatives as well as health and social care professionals or other people in a relationship involving an expectation of trust. Reporting experiences of abuse is associated with poor health outcomes. Still, abusive experiences are often unknown to professionals.

This study protocol describes the development and procedure to test the validity of two new screening instruments (REAGERA-S20 and REAGERA-N) to detect abuse of people with dementia. The aims of the study are:

1. To assess the validity of two new self-administered screening tools to detect abusive experiences among people with dementia: the REAGERA-S20 directed at people with dementia and the REAGERA-N directed at the next of kin.
2. To translate and validate a Swedish version of the Risk of Elder Abuse and Mistreatment Instrument (REAMI) that can be used by professional caregivers to estimate risk of maltreatment and abuse of people with dementia.
3. To explore experiences of abuse among people with dementia and their next of kin.

Method People with mild to moderate dementia (n=80) and their next of kin (n=80) are recruited at health and social care facilities providing care to people with dementia. In cases of severe dementia or when the person with dementia is excluded for other reasons, only next of kin is included.

The following steps are used in the data collection

1. Participants fill out the REAGERA-S20 or REAGERA-N individually.
2. Participants are interviewed individually by two different researchers about their abusive experiences. If a participant talks about abusive experiences, a qualitative in-depth interview about those experiences is conducted.
3. A preliminary classification of the participants as abused or not abused, based only on information provided in the individual interview is made.
4. Information provided in the two individual interviews are compared by the researchers. If needed, and with permission obtained individually from the participants, a joint concluding interview is conducted to clarify inconsistencies.
5. A final classification of participants experiences of abuse is made based on the information provided in both interviews.

The validity of the REAGERA-S20/REAGERA-N will be calculated using the following classification of participants made in the interviews as gold standard (aim 1):

For the person with dementia

* Reporting or not reporting abusive experiences during the past 12 months.
* Reporting or not reporting abusive experience earlier in life, i.e. more than 12 months ago.

For the next of kin

* Reporting or not reporting own exposure to abuse by the person with dementia during the past 12 months.
* Reporting or not reporting own perpetration of abuse towards the person with dementia during the past 12 months.
* Reporting or not reporting that the person with dementia has been exposed to abuse by another person during the past 12 months.
* Reporting or not reporting that the person with dementia has been exposed to abuse earlier in life, i.e. more than 12 months ago.

After completion of data collection, the REAMI is filled out by a health or social care professional with knowledge about the participant with dementia. Validity of the instrument will be calculated using the information provided in the interview as the gold standard (aim 2).

All interviews are recorded and transcribed verbatim. Analyses of the qualitative interviews will be made to explore experiences of abuse among participants (aim 3).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elder Abuse Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

People with dementia

People diagnosed with dementia

No interventions assigned to this group

Next of kin

Next of kin to people with dementia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient: Being diagnosed with dementia of mild to moderate degree (assessed by the Global Deterioration Scale (GDS) level 4 or 5)
* Next of kin: Being the next of kin to a person with dementia, GDS = 4-7

Exclusion Criteria

* Both patient and next of kin: Severe psychiatric disorder, not being able to answer the questionnaires or participate in an interview, e.g. due to insufficient proficiency in Swedish, aphasia, hearing loss or similar.
* People with dementia: experiencing symptoms that may be exacerbated by study participation or make results less reliable (e.g. paranoia).
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Linkoeping University

OTHER_GOV

Sponsor Role collaborator

Jonkoping County Hospital

OTHER

Sponsor Role collaborator

Jonkoping University

OTHER

Sponsor Role collaborator

Region Östergötland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johanna Simmons

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Region Jönköpings Län

Jönköping, , Sweden

Site Status

Region Östergötland

Linköping, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Simmons J, Floberg E, Casselgren C, Westerlind B, Sandberg J, Swahnberg K, Nagga K, Ludvigsson M, Johansson L. REAGERA-dementia: study protocol for the validation of screening instruments to detect abuse of people with dementia. BMC Geriatr. 2025 Aug 25;25(1):660. doi: 10.1186/s12877-025-06291-z.

Reference Type DERIVED
PMID: 40855257 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://liu.se/en/research/reagera

Webpage of research program

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20210151

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

941250 and 981144

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2021-05822-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CommunityRx-Dementia
NCT04146545 COMPLETED NA